# Effectiveness And Safety Of Frovatriptan For The Management (Acute Treatment) Of Menstrual Migraine

> **NCT00904098** · PHASE4 · COMPLETED · sponsor: **Endo Pharmaceuticals** · enrollment: 192 (actual)

## Conditions studied

- Menstrual Migraine (MM) Headaches

## Interventions

- **DRUG:** Frovatriptan
- **DRUG:** Usual Care

## Key facts

- **NCT ID:** NCT00904098
- **Lead sponsor:** Endo Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2006-02
- **Final completion:** 2006-02
- **Target enrollment:** 192 (ACTUAL)
- **Last updated:** 2010-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00904098

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00904098, "Effectiveness And Safety Of Frovatriptan For The Management (Acute Treatment) Of Menstrual Migraine". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00904098. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*